Berwyn, Pennsylvania-based AMETEK, Inc. (AME) manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices. Valued at a market cap of $48.1 billion, the company serves a diverse range of end markets, including aerospace, defense, medical, industrial, energy, and research applications. It is scheduled to announce its fiscal Q4 earnings for 2025 in the near future.
Before this event, analysts expect this industrial company to report a profit of $1.94 per share, up 3.7% from $1.87 per share in the year-ago quarter. The company has surpassed Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $1.89 per share in the previous quarter exceeded the forecasted figure by 7.4%.
For the current fiscal year, ending in December, analysts expect AME to report a profit of $7.36 per share, up 7.8% from $6.83 per share in fiscal 2024. Furthermore, its EPS is expected to grow 8% year-over-year to $7.95 in fiscal 2026.
Shares of AME have surged 17.7% over the past 52 weeks, outperforming the S&P 500 Index's ($SPX) 16.2% return over the same time frame. However, it has lagged behind the State Street Industrial Select Sector SPDR ETF’s (XLI) 20.4% uptick over the same time period.
On Oct. 30, shares of AME gained 7.7% after its better-than-expected Q3 earnings release. The company delivered record sales and adjusted earnings in the quarter. Its net sales climbed 10.8% year-over-year to $1.9 billion, surpassing consensus expectations by 3.8%. Furthermore, its adjusted EPS of $1.89 exceeded the forecasted figure by 7.4%.
Wall Street analysts are moderately optimistic about AME’s stock, with a "Moderate Buy" rating overall. Among 18 analysts covering the stock, 11 recommend "Strong Buy," one indicates a “Moderate Buy,” and six suggest "Hold.” The mean price target for AME is $224, indicating a 6% potential upside from the current levels.
On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
